A standoff with shareholders dating back to 2014 has finally ended with Mayne Pharma (ASX: MYX) agreeing to settle a…
In FY23, pharmaceutical company Mayne Pharma (ASX: MYX) reimagined its business to focus on dermatology and other core businesses. In…
Once one of the biggest names in the pharmaceuticals industry, Mayne Pharma (ASX: MYX) has suffered a string of bad…
Bloating, weight gain, mood swings, headaches. Just a handful of the not so lovely side effects bestowed upon women by…